457 ADALIMUMAB FOR PATIENTS WITH CROHN'S DISEASE COMPLICATED BY INTRA-ABDOMINAL ABSCESS : LONG-TERM RESULTS OF THE MICA STUDY
Guillaume Pineton de Chambrun, Yoram Bouhnik(Clinique Ambroise Paré), Stéphane Nancey, Médina Boualit(Centre Hospitalier de Valenciennes), Alexandre Aubourg(Centre Hospitalier Universitaire de Tours), Arnaud Bourreille(European CanCer Organisation), Aurélien Amiot(Université Paris-Est Créteil), Laurent Peyrin‐Biroulet(Délégation Centre-Est), Véred Abitbol(Hôpital Cochin), Benjamin Pariente(New Leaders), Jérôme Lambert(Délégation Paris 7), Mélanie Serrero(Assistance Publique Hôpitaux de Marseille), Anthony Buisson(Centre Hospitalier Universitaire de Clermont-Ferrand), Lucine Vuitton(Centre Hospitalier Universitaire de Besançon), Philippe Seksik(Inserm), Georgia Malamut(Délégation Paris 5), Romain Altwegg(Université de Montpellier), Maria Nachury(Centre Hospitalier Universitaire de Lille), Magaly Zappa, Carmen Stéfanescu(Clinique Hartmann), Nina Dib(Université d'Angers), Kristell Desseaux(Inserm), Jacques Moreau(Centre Hospitalier Universitaire de Toulouse), Stéphanie Viennot(Centre Hospitalier Universitaire de Besançon), Jérôme Filippi(Centre Hospitalier Universitaire de Nice), Xavier Roblin(Centre Hospitalier Universitaire de Saint-Étienne)
Cited by 2
Related Papers
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Potential of fecal microbiota for early‐stage detection of colorectal cancer
|Molecular Systems Biology|2014|1.4k
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2019|1.2k
Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines
|Journal of Crohn s and Colitis|2013|669